Effect of henagliflozin on left ventricular mass index in dialysis patients with HFpEF (HELD-HF): protocol for a multicentre, randomised, double-blind, placebo-controlled trial.
Hao YanWei WangYing LiYinghui QiRenhua LuYijun ZhouWeiming ZhangShang LiuHuihua PangYan FangZhenyuan LiJieying WangMeng JiangZhi-Chun GuLeyi GuWei FangPublished in: BMJ open (2024)
ChiCTR2300073169.
Keyphrases
- double blind
- left ventricular
- placebo controlled
- clinical trial
- chronic kidney disease
- end stage renal disease
- randomized controlled trial
- heart failure
- study protocol
- hypertrophic cardiomyopathy
- cardiac resynchronization therapy
- phase iii
- acute myocardial infarction
- mitral valve
- aortic stenosis
- phase ii
- acute heart failure
- left atrial
- peritoneal dialysis
- open label